Sequester May Further Depress AmerisourceBergen’s Oncology Drug Sales
Executive Summary
Wholesalers AmerisourceBergen and McKesson discuss the potential impact of the federal budget sequester and the resulting cut to Part B drug reimbursement on oncology drug sales.